文献速递糖尿病

体重变化与磺脲类药物治疗与2型糖尿病患者3年微血管功能变化相关

Weight change and sulfonylurea therapy are related to 3 year change in microvascular function in people with type 2 diabetes.
PubMed 文献 · Diabetologia · 2020-03-17

研究纳入154例2型糖尿病患者和99例无糖尿病者,用激光多普勒血流仪测量皮肤微血管内皮依赖与非依赖功能,3年后复测。2型糖尿病患者基线微血管反应受损,两组3年下降程度相似;全人群中3年体重变化是微血管功能变化的主要决定因素,减重≥5%者功能下降很小,增重者下降更大,该关联由糖尿病患者驱动。

要点

  • 2型糖尿病患者基线内皮依赖与非依赖微血管反应均低于无糖尿病者。
  • 两组3年微血管功能下降程度相似,交互作用P值分别为0.74和0.69。
  • 全人群中3年体重变化是微血管功能变化的主要决定因素,减重≥5%者下降很小。

核心结论

  • 3年期间,生理性体重变化是微血管功能变化的最大预测因素。

研究设计与样本

  • 研究纳入154例2型糖尿病患者和99例无2型糖尿病者,基线采集人口学资料,使用激光多普勒血流仪测量皮肤微血管对乙酰胆碱离子导入的内皮依赖反应和对硝普钠的内皮非依赖反应,3年后重复全部评估。

主要发现

  • 2型糖尿病患者内皮依赖微血管反应低于无糖尿病者,曲线下面积(AUC)93.9(95%CI 88.1,99.4)vs 111.9(95%CI 102.3,121.4)AU×min,p<0.001。
  • 2型糖尿病患者内皮非依赖反应亦低于无糖尿病者,63.2(95%CI 59.2,67.2)vs 75.1(95%CI 67.8,82.4)AU×min,p=0.002。
  • 两组3年微血管功能平均下降程度相似,乙酰胆碱反应交互作用p=0.74,硝普钠反应交互作用p=0.69。
  • 在糖尿病患者中,使用磺脲类药物与更大幅度的下降相关(校正合并处方、HbA1c变化和体重后p=0.022),而改善血糖控制与内皮依赖微血管功能下降较少相关(p=0.03)。
  • 全人群中,减重≥5%者内皮依赖功能变化为1.2(95%CI -13.2,15.7)AU×min,体重稳定者为-15.8(95%CI -10.5,-21.0)AU×min,增重者为-37.8(95%CI -19.4,-56.2)AU×min,趋势p<0.001;该关联由糖尿病患者驱动,无糖尿病者中关系不显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Although cardiovascular disease is the biggest cause of death in people with diabetes, microvascular complications have a significant impact on quality of life and financial burden of the disease. Little is known about the progression of microvascular dysfunction in the early stages of type 2 diabetes before the occurrence of clinically apparent complications. We aimed to explore the determinants of endothelial-dependent and -independent microvascular function progression over a 3 year period, in people with and without both diabetes and few clinical microvascular complications. METHODS: Demographics were collected in 154 participants with type 2 diabetes and in a further 99 participants without type 2 diabetes. Skin microvascular endothelium-dependent response to iontophoresis of acetylcholine and endothelium-independent responses to sodium nitroprusside were measured using laser Doppler fluximetry. All assessments were repeated 3 years later. RESULTS: People with type 2 diabetes had impaired endothelial-dependent microvascular response compared with those without (AUC 93.9 [95% CI 88.1, 99.4] vs 111.9 [102.3, 121.4] arbitrary units [AU] × min, p < 0.001, for those with vs without diabetes, respectively). Similarly, endothelial-independent responses were attenuated in those with diabetes (63.2 [59.2, 67.2] vs 75.1 [67.8, 82.4] AU × min, respectively, p = 0.002). Mean microvascular function declined over 3 years in both groups to a similar degree (pinteraction 0.74 for response to acetylcholine and 0.69 for response to sodium nitroprusside). In those with diabetes, use of sulfonylurea was associated with greater decline (p = 0.022 after adjustment for co-prescriptions, change in HbA1c and weight), whereas improving glycaemic control was associated with less decline of endothelial-dependent microvascular function (p = 0.03). Otherwise, the determinants of microvascular decline were similar in those with and without diabetes. The principal determinant of change in microvascular function in the whole population was weight change over 3 years, such that those that lost ≥5% weight had very little decline in either endothelial-dependent or -independent function compared with those that were weight stable, whereas those who gained weight had a greater decline in function (change in endothelial-dependent function was 1.2 [95% CI -13.2, 15.7] AU × min in those who lost weight; -15.8 [-10.5, -21.0] AU × min in those with stable weight; and -37.8 [-19.4, -56.2] AU × min in those with weight gain; ptrend < 0.001). This association of weight change with change in endothelial function was driven by people with diabetes; in people without diabetes, the relationship was nonsignificant. CONCLUSIONS/INTERPRETATION: Over 3 years, physiological change in weight was the greatest predictor of change in microvascular function.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Casanova F, Gooding KM, Shore AC, et al. Weight change and sulfonylurea therapy are related to 3 year change in microvascular function in people with type 2 diabetes. Diabetologia. 2020. PMID: 32185461. doi:10.1007/s00125-020-05125-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。